For example, most low-grade astrocytomas seem to require mutations in BRAF, RAS and IDH or might follow a different line of progression involving TP53, PDGFR and loss of heterozygosity (LOH) at 22q or p14 promoter methylation. This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).